Dual pH-triggered multistage drug delivery systems based on host–guest interaction-associated polymeric nanogels
- 2 June 2014
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 50 (58) , 7824-7827
Abstract
The polymeric nanogels were constructed via host–guest interactions for dual pH-triggered multistage drug delivery, which showed tumor acidity-triggered nanogel reorganization into smaller nanoparticles for deep tissue penetration, high-efficiency cellular uptake, and intracellular endo-lysosomal pH-responsive drug release.Keywords
This publication has 27 references indexed in Scilit:
- Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performanceChemical Society Reviews, 2013
- Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: Concepts and applicationsAdvanced Drug Delivery Reviews, 2012
- Photoswitchable Nanoparticles for Triggered Tissue Penetration and Drug DeliveryJournal of the American Chemical Society, 2012
- Targeted polymeric therapeutic nanoparticles: design, development and clinical translationChemical Society Reviews, 2012
- Supramolecular Nanodevices: From Design Validation to Theranostic NanomedicineAccounts of Chemical Research, 2011
- Multistage nanoparticle delivery system for deep penetration into tumor tissueProceedings of the National Academy of Sciences, 2011
- Delivering nanomedicine to solid tumorsNature Reviews Clinical Oncology, 2010
- Polymer conjugates as anticancer nanomedicinesNature Reviews Cancer, 2006
- Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast CancerJournal of Clinical Oncology, 2005
- Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancerAnnals of Oncology, 2004